Cargando…

A Proposal of a Personalized Surveillance Strategy for Gastric Cancer: A Retrospective Analysis of 9191 Patients

BACKGROUND: In gastric cancer, various surveillance strategies are suggested in international guidelines. The current study is intended to evaluate the current strategies and provide more personalized proposals for personalized cancer medicine. MATERIALS AND METHODS: In the aggregate, 9191 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Si-wei, Wang, Peng-liang, Huang, Han-wei, Luo, Lei, Wang, Xin, Wang, Tao, Liu, Fu-nan, Xu, Hui-mian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362503/
https://www.ncbi.nlm.nih.gov/pubmed/30804994
http://dx.doi.org/10.1155/2019/3248727
_version_ 1783392932148019200
author Pan, Si-wei
Wang, Peng-liang
Huang, Han-wei
Luo, Lei
Wang, Xin
Wang, Tao
Liu, Fu-nan
Xu, Hui-mian
author_facet Pan, Si-wei
Wang, Peng-liang
Huang, Han-wei
Luo, Lei
Wang, Xin
Wang, Tao
Liu, Fu-nan
Xu, Hui-mian
author_sort Pan, Si-wei
collection PubMed
description BACKGROUND: In gastric cancer, various surveillance strategies are suggested in international guidelines. The current study is intended to evaluate the current strategies and provide more personalized proposals for personalized cancer medicine. MATERIALS AND METHODS: In the aggregate, 9191 patients with gastric cancer after gastrectomy from 1998 to 2009 were selected from the Surveillance, Epidemiology, and End Results database. Disease-specific survival was analyzed by Kaplan-Meier method and the log-rank test. Cox proportional hazards regression analyses were used to confirm the independent prognostic factors. As well, hazard ratio (HR) curves were used to compare the risk of death over time. Conditional survival (CS) was applied to dynamically assess the prognosis after each follow-up. RESULTS: Comparisons from HR curves on different stages showed that earlier stages had distinctly lower HR than advanced stages. The curve of stage IIA was flat and more likely the same as that of stage I while that of stage IIB is like that of stage III with an obvious peak. After estimating CS at intervals of three months, six months, and 12 months in different periods, stages I and IIA had high levels of CS all along, while there were visible differences among CS levels of stages IIB and III. CONCLUSIONS: The frequency of follow-up for early stages, like stages I and IIA, could be every six months or longer in the first three years and annually thereafter. And those with unfavorable conditions, such as stages IIB and III, could be followed up much more frequently and sufficiently than usual.
format Online
Article
Text
id pubmed-6362503
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-63625032019-02-25 A Proposal of a Personalized Surveillance Strategy for Gastric Cancer: A Retrospective Analysis of 9191 Patients Pan, Si-wei Wang, Peng-liang Huang, Han-wei Luo, Lei Wang, Xin Wang, Tao Liu, Fu-nan Xu, Hui-mian Gastroenterol Res Pract Research Article BACKGROUND: In gastric cancer, various surveillance strategies are suggested in international guidelines. The current study is intended to evaluate the current strategies and provide more personalized proposals for personalized cancer medicine. MATERIALS AND METHODS: In the aggregate, 9191 patients with gastric cancer after gastrectomy from 1998 to 2009 were selected from the Surveillance, Epidemiology, and End Results database. Disease-specific survival was analyzed by Kaplan-Meier method and the log-rank test. Cox proportional hazards regression analyses were used to confirm the independent prognostic factors. As well, hazard ratio (HR) curves were used to compare the risk of death over time. Conditional survival (CS) was applied to dynamically assess the prognosis after each follow-up. RESULTS: Comparisons from HR curves on different stages showed that earlier stages had distinctly lower HR than advanced stages. The curve of stage IIA was flat and more likely the same as that of stage I while that of stage IIB is like that of stage III with an obvious peak. After estimating CS at intervals of three months, six months, and 12 months in different periods, stages I and IIA had high levels of CS all along, while there were visible differences among CS levels of stages IIB and III. CONCLUSIONS: The frequency of follow-up for early stages, like stages I and IIA, could be every six months or longer in the first three years and annually thereafter. And those with unfavorable conditions, such as stages IIB and III, could be followed up much more frequently and sufficiently than usual. Hindawi 2019-01-22 /pmc/articles/PMC6362503/ /pubmed/30804994 http://dx.doi.org/10.1155/2019/3248727 Text en Copyright © 2019 Si-wei Pan et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Pan, Si-wei
Wang, Peng-liang
Huang, Han-wei
Luo, Lei
Wang, Xin
Wang, Tao
Liu, Fu-nan
Xu, Hui-mian
A Proposal of a Personalized Surveillance Strategy for Gastric Cancer: A Retrospective Analysis of 9191 Patients
title A Proposal of a Personalized Surveillance Strategy for Gastric Cancer: A Retrospective Analysis of 9191 Patients
title_full A Proposal of a Personalized Surveillance Strategy for Gastric Cancer: A Retrospective Analysis of 9191 Patients
title_fullStr A Proposal of a Personalized Surveillance Strategy for Gastric Cancer: A Retrospective Analysis of 9191 Patients
title_full_unstemmed A Proposal of a Personalized Surveillance Strategy for Gastric Cancer: A Retrospective Analysis of 9191 Patients
title_short A Proposal of a Personalized Surveillance Strategy for Gastric Cancer: A Retrospective Analysis of 9191 Patients
title_sort proposal of a personalized surveillance strategy for gastric cancer: a retrospective analysis of 9191 patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362503/
https://www.ncbi.nlm.nih.gov/pubmed/30804994
http://dx.doi.org/10.1155/2019/3248727
work_keys_str_mv AT pansiwei aproposalofapersonalizedsurveillancestrategyforgastriccanceraretrospectiveanalysisof9191patients
AT wangpengliang aproposalofapersonalizedsurveillancestrategyforgastriccanceraretrospectiveanalysisof9191patients
AT huanghanwei aproposalofapersonalizedsurveillancestrategyforgastriccanceraretrospectiveanalysisof9191patients
AT luolei aproposalofapersonalizedsurveillancestrategyforgastriccanceraretrospectiveanalysisof9191patients
AT wangxin aproposalofapersonalizedsurveillancestrategyforgastriccanceraretrospectiveanalysisof9191patients
AT wangtao aproposalofapersonalizedsurveillancestrategyforgastriccanceraretrospectiveanalysisof9191patients
AT liufunan aproposalofapersonalizedsurveillancestrategyforgastriccanceraretrospectiveanalysisof9191patients
AT xuhuimian aproposalofapersonalizedsurveillancestrategyforgastriccanceraretrospectiveanalysisof9191patients
AT pansiwei proposalofapersonalizedsurveillancestrategyforgastriccanceraretrospectiveanalysisof9191patients
AT wangpengliang proposalofapersonalizedsurveillancestrategyforgastriccanceraretrospectiveanalysisof9191patients
AT huanghanwei proposalofapersonalizedsurveillancestrategyforgastriccanceraretrospectiveanalysisof9191patients
AT luolei proposalofapersonalizedsurveillancestrategyforgastriccanceraretrospectiveanalysisof9191patients
AT wangxin proposalofapersonalizedsurveillancestrategyforgastriccanceraretrospectiveanalysisof9191patients
AT wangtao proposalofapersonalizedsurveillancestrategyforgastriccanceraretrospectiveanalysisof9191patients
AT liufunan proposalofapersonalizedsurveillancestrategyforgastriccanceraretrospectiveanalysisof9191patients
AT xuhuimian proposalofapersonalizedsurveillancestrategyforgastriccanceraretrospectiveanalysisof9191patients